The sale is small relative to market cap and follows a pattern of periodic vesting-related sales by the director. No material signal for the stock. Monitor for any acceleration in selling volume or a change in pattern (e.g., CEO/CFO selling).
Price Chart
Executive Summary
Director John Oyler filed a Form 144 notice of intent to sell 3,410 ADSs (~$933,592 at the filing date) of BeOne Medicines Ltd. (ONC). The shares were acquired via restricted stock vesting under a registered plan. Oyler has sold a total of 10,582 ADSs (~$2.8M) in the prior three months, including three separate sales in June 2026. The filing signals a planned reduction of insider holdings, though the amount is modest relative to the $30.2B market cap.
Key Facts
- Director John Oyler filed Form 144 to sell 3,410 ADSs (~$933,592) on 2026-06-23.
- Shares were acquired via restricted stock vesting under a registered plan.
- Oyler sold 3,693 ADSs (~$980,686) on 2026-06-16, 1,949 ADSs (~$501,355) on 2026-06-11, and 4,940 ADSs (~$1.34M) on 2026-06-08.
- Total sales by Oyler in the prior three months: 10,582 ADSs (~$2.8M).
- Market cap is $30.2B; the proposed sale represents ~0.003% of shares outstanding.
- Recent insider activity (30d): 5 sells totaling $1.5M (Oyler's sales are the majority).
Financial Impact
Proposed sale of ~$934K in ADSs, representing ~0.003% of market cap
Risk Factors
- Insider selling could accelerate if Oyler files additional Form 144s or Form 4s.
- Historical performance on ONC reports shows poor win rate (0% at T+20) — this neutral read is consistent with the pattern of no material impact from insider filings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006411 |
| Document: 0001950047-26-006411-index.html | 0001950047-26-006411 |
| Document: 0001950047-26-006411.txt | 0001950047-26-006411 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 21d ago | Insider Cluster | $346.51 $350.84 | ▲ +1.25% | ▲ +1.47% | $358.07 (+3.34%) |
Sep 3, 2026 29d ago | Insider Cluster | $362.68 $346.51 | ▼ −4.46% | ▼ −3.31% | $358.07 (−1.27%) |
Aug 26, 2026 5w ago | 8-K | $375.80 $361.78 | ▼ −3.73% | ▼ −3.61% | $358.07 (−4.72%) |
Aug 14, 2026 7w ago | Insider Cluster | $347.48 $374.47 | ▲ +7.77% | ▲ +9.14% | $358.07 (+3.05%) |
Aug 12, 2026 7w ago | Insider Cluster | $356.01 $369.16 | ▲ +3.69% | ▲ +5.66% | $358.07 (+0.58%) |
Aug 10, 2026 7w ago | 144 | $359.27 $369.15 | ▼ −2.75% | ▼ −3.15% | $358.07 (+0.33%) |
Aug 5, 2026 8w ago | Insider Cluster | $329.80 $356.01 | ▲ +7.95% | ▲ +6.73% | $358.07 (+8.57%) |
Aug 5, 2026 8w ago | 8-K | $327.53 $359.05 | ▲ +9.62% | ▲ +9.27% | $358.07 (+9.32%) |
Jul 24, 2026 10w ago | Insider Cluster | $325.90 $322.08 | ▼ −1.17% | ▼ −1.55% | $358.07 (+9.87%) |
Jul 17, 2026 11w ago | Insider Cluster | $312.02 $326.77 | ▼ −4.73% | ▼ −5.41% | $358.07 (−14.76%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access